Locations:
Search IconSearch

Surgeons Continue to Improve Robotic Radical Cystectomy Processes and Outcomes

Innovations include 3 intracorporeal urinary diversion techniques

650×450-Haber-Bladder

Glickman Urological & Kidney Institute urologists have performed more than 350 robotic cystectomies with intracorporeal urinary diversions, more than any other center in the United States and the second highest number in the world.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Just a few years ago, the same surgeons typically performed radical cystectomies using an open surgical approach that required a seven- to 10-day hospitalization. About 60 percent of those patients developed postsurgical complications, such as ileus, the temporary arrest of intestinal peristalsis, which causes nausea, vomiting and abdominal bloating.

Today, the team performs most radical cystectomies via a minimally invasive robotic approach, and patients are often discharged after a four- to five-day hospitalization. In addition, the urologists have gone a step further, performing many urinary diversions robotically, which allows them to avoid making another incision and exposing the bowels for this part of the procedure.

“Currently, most centers that perform radical cystectomy robotically will convert to an open approach for the urinary diversion,” explains urologist Georges-Pascal Haber, MD, PhD. “We developed a technique for robotic intracorporeal urinary diversion after bladder removal. We have used this technique to form the three major types of urinary diversion: ileal conduit, continent catheterizable pouch, and neobladder, and we found that the robotic technique has improved clinical outcomes.”

Robotic intracorporeal urinary diversions are challenging technically. But the benefits are significant and include smaller incisions, reduced postoperative pain, diminished bowel handling and exposure, and reduced risk of fluid imbalance.

“Most important,” says Byron Lee, MD, PhD, urologic oncologist and researcher, “we haven’t seen a difference in cancer control, whether we perform the cystectomy open or robotically. Additionally, there is no difference in cancer control between extracorporeal or intracorporeal urinary diversion. Many of us are now performing intracorporeal urinary diversions because of the benefit to the patient immediately after surgery.”

Advertisement

ERAP program for cystectomy

An enhanced recovery after procedures (ERAP) program covering pre-, intra- and postoperative periods has improved postoperative outcome metrics as well. The program addresses a number of factors that enhance patient recovery after surgery. Some of the essential elements include intense perioperative patient education, avoiding fasting and bowel prep which can deplete the body of vital fluids and nutrition immediately before surgery, avoiding nasogastric tube placement, minimizing opioid use, and encouraging early ambulation in the recovery phase. The program has reduced overall length of stay by 29 percent, postsurgery emergency department visits by 40 percent, readmissions by 39 percent, and costs by 14 percent.

Robotic radical cystectomy proocedure

Distance health

Drs. Lee and Haber also are exploring a form of distance health to lower complication rates. Dehydration is a problem that can land radical cystectomy patients back in the hospital if fluid intake is inadequate after discharge.

“It could be that the patient’s bowels aren’t functioning perfectly after surgery, so their appetite is not the best,” says Dr. Lee. “But we do not have a good way to monitor intake post-discharge. Readmission due to dehydration is hard on the patient, and of course costly.”

He and Dr. Haber are experimenting with giving patients “smart bottles” that can record a patient’s fluid intake and send the data to a cloud server where doctors can access and assess it.

“We are always looking for opportunities to improve care that could result in better outcomes,” says Dr. Haber.

Advertisement

Related Articles

CT scan of female patient bladder cancer
November 26, 2024/Urology & Nephrology/Urology
Use of Interim Imaging To Preserve Eligibility for Vaginal-Sparing Cystectomy

Retrospective study evaluates clinical upstaging during neoadjuvant treatment

Microscopic view of bladder cancer with variant histology
November 19, 2024/Urology & Nephrology/Urology
Nonmuscle Invasive Bladder Cancer With Variant Histology: When To Consider a Bladder-Sparing Approach

Retrospective study finds acceptable cancer control among most histologic subtypes with intravesical therapy

Single-port robot docked in the operating room
November 12, 2024/Urology & Nephrology/Urology
Single-Port Pyeloplasty in a Pediatric Patient: A Novel Surgical Technique

Revolutionizing pediatric urology with a new, less invasive approach

Physician smiles at patient in a preoperative setting
September 12, 2024/Urology & Nephrology/Urology
Improving the Bladder Cancer Survivorship Experience for Women

What updated techniques, counseling and a changing workforce could mean

Surgeons in the operating room with the single-port robot
Novel Single-Port Robotic Urology Surgery Surpasses 1,000 Cases

Applications, outcomes and untapped potential

Photo of Dr. Bajic
Counseling Your Patients on SGLT-2 Inhibitors and Adverse Urologic Outcomes

Retrospective study shows SGLT-2 inhibitors may lead to worse urologic outcomes

Illustration of red blood cells in motion
Review Underscores Impact of Red Blood Cell Disorders on Male Reproduction

Early, individualized diagnosis and comprehensive management key to preserving fertility

UTI bacteria and artificial intelligence
AI Algorithms Accurately Predict Antibiotic Resistance in UTI

Up to 3 days faster than waiting for urine culture results

Ad